Literature DB >> 3768416

Isolation and purification of a low-molecular-weight skeletal growth factor from human bones.

S Mohan, J C Jennings, T A Linkhart, D J Baylink.   

Abstract

A low-molecular-weight potent bone cell mitogen termed human skeletal growth factor (human SGF) was purified to homogeneity from human bone matrix. Extraction and initial purification steps were done under dissociative conditions to separate human SGF from high-molecular-weight complexes of bone matrix proteins. SGF activity was extracted from human femoral heads by demineralization with 10% EDTA in the presence of 4 M guanidine-HCl and proteinase inhibitors and was purified by hydroxyapatite, HPLC gel-filtration and HPLC reverse-phase chromatography. Human SGF thus purified was homogeneous by HPLC reverse-phase chromatography and SDS-polyacrylamide gel electrophoresis. The relative molecular mass of human SGF purified under dissociative conditions was 11,000. Human SGF stimulated bone cell proliferation ([3H]thymidine incorporation and cell number) at picomolar concentrations, with half maximum activity at 2-3 ng/ml (180-270 pM). Human SGF constitutes 0.00024% of organic bone matrix by weight.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3768416     DOI: 10.1016/0304-4165(86)90168-6

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  6 in total

1.  Isolation of an inhibitory insulin-like growth factor (IGF) binding protein from bone cell-conditioned medium: a potential local regulator of IGF action.

Authors:  S Mohan; C M Bautista; J Wergedal; D J Baylink
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

2.  Effect of mechanical stimulation on the production of soluble bone factors in cultured fetal mouse calvariae.

Authors:  J Klein-Nulend; C M Semeins; J P Veldhuijzen; E H Burger
Journal:  Cell Tissue Res       Date:  1993-03       Impact factor: 5.249

3.  Vitamin D deficiency causes a selective reduction in deposition of transforming growth factor beta in rat bone: possible mechanism for impaired osteoinduction.

Authors:  R D Finkelman; T A Linkhart; S Mohan; K H Lau; D J Baylink; N H Bell
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-01       Impact factor: 11.205

4.  An age-related decrease in the concentration of insulin-like growth factor binding protein-5 in human cortical bone.

Authors:  V Nicolas; S Mohan; Y Honda; A Prewett; R D Finkelman; D J Baylink; J R Farley
Journal:  Calcif Tissue Int       Date:  1995-09       Impact factor: 4.333

5.  Ovariectomy selectively reduces the concentration of transforming growth factor beta in rat bone: implications for estrogen deficiency-associated bone loss.

Authors:  R D Finkelman; N H Bell; D D Strong; L M Demers; D J Baylink
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

6.  In vitro evidence that local and systemic skeletal effectors can regulate 3[H]-thymidine incorporation in chick calvarial cell cultures and modulate the stimulatory actions(s) of embryonic chick bone extract.

Authors:  J R Farley; N M Tarbaux; J P Vermeiden; D J Baylink
Journal:  Calcif Tissue Int       Date:  1988-01       Impact factor: 4.333

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.